Tammi L. Gaskins - May 16, 2025 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: Chief Commercial Officer
Signature: /s/ Brian Tessler, Attorney-in-Fact
Stock symbol: IRWD
Transactions as of: May 16, 2025
Transactions value $: -$1,487
Form type: 4
Date filed: 5/20/2025, 04:10 PM
Previous filing: Mar 21, 2025
Next filing: Aug 13, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gaskins Tammi L	Chief Commercial Officer	C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON	/s/ Brian Tessler, Attorney-in-Fact	2025-05-20	0002061679

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	-$1.49K	-2.56K	-1.05%	$0.58	243K	May 16, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.